IRIS
VIOLA, Anna
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 723
NA - Nord America 638
AS - Asia 359
SA - Sud America 176
AF - Africa 11
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
Totale 1.911
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 630
IE - Irlanda 239
SG - Singapore 228
IT - Italia 189
SE - Svezia 181
BR - Brasile 161
CN - Cina 95
DE - Germania 24
AT - Austria 14
PL - Polonia 14
FI - Finlandia 12
FR - Francia 9
HK - Hong Kong 9
IN - India 8
GB - Regno Unito 7
AR - Argentina 6
NL - Olanda 6
RU - Federazione Russa 6
BE - Belgio 5
CA - Canada 4
ID - Indonesia 4
MA - Marocco 4
EC - Ecuador 3
IQ - Iraq 3
KE - Kenya 3
LT - Lituania 3
MX - Messico 3
NO - Norvegia 3
BD - Bangladesh 2
CO - Colombia 2
CZ - Repubblica Ceca 2
NZ - Nuova Zelanda 2
RO - Romania 2
RS - Serbia 2
UA - Ucraina 2
VE - Venezuela 2
ZA - Sudafrica 2
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
BG - Bulgaria 1
CL - Cile 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EU - Europa 1
GR - Grecia 1
HU - Ungheria 1
JO - Giordania 1
JP - Giappone 1
KZ - Kazakistan 1
LK - Sri Lanka 1
PK - Pakistan 1
SN - Senegal 1
TR - Turchia 1
UY - Uruguay 1
UZ - Uzbekistan 1
VN - Vietnam 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 1.911
Salva come PNG Salva come JPEG
Città #
Dublin 237
Chandler 169
Singapore 115
Nyköping 94
Ashburn 65
Messina 54
Princeton 37
Medford 33
Des Moines 24
Los Angeles 15
Ann Arbor 13
Milan 13
Seattle 12
Vienna 12
São Paulo 11
Beijing 9
Hong Kong 9
Jinan 9
Nuremberg 9
Rome 8
Dearborn 7
Munich 7
Pozzuolo Martesana 6
Wilmington 6
Belo Horizonte 5
Brussels 5
Council Bluffs 5
Hebei 5
Jacksonville 5
London 5
Nanjing 5
Tianjin 5
Cagliari 4
Curitiba 4
Haikou 4
Hangzhou 4
Helsinki 4
Jakarta 4
Porto Alegre 4
Pune 4
Shenyang 4
Zhengzhou 4
Bremen 3
Campinas 3
Changsha 3
Fuzhou 3
Lappeenranta 3
Mineo 3
Nairobi 3
Ningbo 3
Rio de Janeiro 3
Trecastagni 3
Amsterdam 2
Auckland 2
Baghdad 2
Boardman 2
Bogotá 2
Brasília 2
Cambridge 2
Cariacica 2
Carini 2
Enna 2
Guangzhou 2
Handan 2
Hyderabad 2
Indaiatuba 2
Jiaxing 2
Lanzhou 2
Mogi das Cruzes 2
New York 2
Osasco 2
Oslo 2
Ottawa 2
Palmas 2
Pelotas 2
Ponta Grossa 2
Prague 2
Recife 2
Reggio Calabria 2
Reggio Nell'emilia 2
Salvador 2
Santa Inês 2
Santa Maria da Vitória 2
Shanghai 2
Squillace 2
Toronto 2
Trezzo Sull'adda 2
Venaria Reale 2
Vitória da Conquista 2
Abreu e Lima 1
Afonso Cláudio 1
Agadir 1
Agrolândia 1
Almirante Tamandaré 1
Alta Floresta 1
Amman 1
Anchieta 1
Anápolis 1
Araruama 1
Astana 1
Totale 1.169
Salva come PNG Salva come JPEG
Nome #
Late-onset Crohn's disease: a comparison of disease behaviour and therapy with younger adult patients: the Italian Group for the Study of Inflammatory Bowel Disease 'AGED' study 89
Comparative Efficacy of Vedolizumab and Adalimumab in Ulcerative Colitis Patients Previously Treated With Infliximab 73
Outcome in ulcerative colitis after switch from adalimumab/golimumab to infliximab: A multicenter retrospective study 71
Disease patterns in late-onset ulcerative colitis: Results from the IG-IBD “AGED study” 70
Diagnostic accuracy of faecal calprotectin in a symptom-based algorithm for early diagnosis of inflammatory bowel disease adjusting for differential verification bias using a Bayesian approach 68
Cancer risk in inflammatory bowel disease: a 6-year prospective multicenter nested case-control IG-IBD study 67
Inflammatory Bowel Disease in the Elderly – Knowledge Gaps and Potential Directions in Research 66
A propensity score weighted comparison of Vedolizumab, Adalimumab, and Golimumab in patients with ulcerative colitis 60
Direct oral anticoagulants increase the risk of anaemia and hospitalization in IBD patients with active intestinal disease 60
DWI ratios: New indexes for Crohn's disease activity at magnetic resonance enterography? 57
Effectiveness and safety of vedolizumab in biologically naïve patients: A real-world multi-centre study 57
Effectiveness of Ustekinumab on Crohn‘s Disease Associated Spondyloarthropathy: Real-World Data from the Sicilian Network for Inflammatory Bowel Diseases (SN-IBD) 53
One-year effectiveness and safety of ustekinumab in ulcerative colitis: a multicenter real-world study from Italy 52
Tissue levels of Tumour Necrosis Factor-alpha as molecular biomarker of inflammation and prediction of sustained treatment response in patients with Ulcerative Colitis. 52
Effectiveness and Safety Profiles of Biological Therapies in Inflammatory Bowel Disease: Real Life Data from an Active Pharmacovigilance Project 50
Effectiveness and safety of vedolizumab in a matched cohort of elderly and nonelderly patients with inflammatory bowel disease: The IG-IBD LIVE study 50
The PROSIT-BIO Cohort: A Prospective Observational Study of Patients with Inflammatory Bowel Disease Treated with Infliximab Biosimilar 49
Management of patients with inflammatory bowel disease and outcomes during the first wave of the Covid-19 pandemic 47
The SPOSIB SB2 Sicilian Cohort: Safety and Effectiveness of Infliximab Biosimilar SB2 in Inflammatory Bowel Diseases, Including Multiple Switches 45
Dual Targeted Therapy: a possible option for the management of refractory Inflammatory Bowel Disease 45
Telemedicine and Remote Screening for COVID-19 in Inflammatory Bowel Disease Patients: Results from the SoCOVID-19 Survey 44
Stevens-Johnson syndrome on treatment with sulfasalazine for Crohn’s disease: Need for a multidisciplinary approach 43
IL PAZIENTE ANZIANO CON MALATTIA INFIAMMATORIA CRONICA INTESTINALE: OSSERVAZIONI IN UN GRUPPO DI PAZIENTI AMBULATORIALI 43
null 40
Incident Colorectal Cancer in Inflammatory Bowel Disease 39
Prevalence, Pathogenesis and Management of Anemia in Inflammatory Bowel Disease: An IG-IBD Multicenter, Prospective, and Observational Study 38
Role of IL-33/ST2 Pathway in Inflammatory Bowel Disease: An Overview and Future Perspectives 36
null 33
Persistence on Anti-Tumour Necrosis Factor Therapy in Older Patients with Inflammatory Bowel Disease Compared with Younger Patients: Data from the Sicilian Network for Inflammatory Bowel Diseases (SN-IBD) 33
Ménétrier's disease in a patient with refractory ulcerative colitis: a clinical challenge and review of the literature 33
Comparison of two strategies for the management of postoperative recurrence in Crohn's disease patients with one clinical risk factor: A multicentre IG-IBD study 30
Objective comparison of vedolizumab and ustekinumab effectiveness in Crohn's disease patients failure to TNF-alpha inhibitors 30
Ustekinumab in Crohn's disease: Real-world outcomes from the Sicilian network for inflammatory bowel diseases 28
Letter: the clinical course of Crohn's disease—the Sicilian experience 28
Portal hypertensive enteropathy: multimodality assessment through computed tomography and magnetic resonance enterography 26
Efficacy and Safety of Biological Therapies and JAK Inhibitors in Older Patients with Inflammatory Bowel Disease 26
Two-year effectiveness and safety of golimumab in ulcerative colitis: An IG-IBD study 26
Safety and efficacy of combining biologics or small molecules for inflammatory bowel disease or immune-mediated inflammatory diseases: A European retrospective observational study 26
Quality of Life (QoL) in Patients with Chronic Inflammatory Bowel Diseases: How Much Better with Biological Drugs? 24
SPOSAB ABP 501 - A Sicilian Prospective Observational Study of Patients with Inflammatory Bowel Disease Treated with Adalimumab Biosimilar ABP 501 22
Vedolizumab may be an effective option for the treatment of postoperative recurrence of Crohn's disease 21
Predictors of Covid-19 vaccination acceptance in IBD patients: a prospective study 21
Rates of Adverse Events in Patients With Ulcerative Colitis Undergoing Colectomy During Treatment With Tofacitinib vs Biologics: A Multicenter Observational Study 20
Effectiveness of adalimumab for ulcerative colitis: A multicentre, retrospective study of clinical practice in Italy 20
Ultrasonography tight control and monitoring in crohn's disease during different biological therapies: a multicenter study 19
Activities related to inflammatory bowel disease management during and after the coronavirus disease 2019 lockdown in Italy: How to maintain standards of care 18
DWI ratios at MR-Enterography: a new way for inflammation degree assessment in Crohn's disease patients? 17
A real world investigation on prevalence, clinical features, and therapy of inflammatory bowel disease in the city of Messina, Italy 16
Low Adherence is Associated with Chronic Active Disease in Ulcerative Colitis: A Retrospective Study from a Single Referral Center 13
Mitigating the Risk of Tofacitinib-induced Adverse Events in the Elderly Population with Ulcerative Colitis 12
Ulcerative Colitis in Adulthood and in Older Patients: Same Disease, Same Outcome, Same Risks? 12
A propensity score weighted comparison of vedolizumab and adalimumab in Crohn's disease 10
Epidemiology and clinical course of late onset inflammatory bowel disease 10
Severe Activity of Inflammatory Bowel Disease is a Risk Factor for Severe COVID-19 8
Corticosteroid use in patients with inflammatory bowel diseases: A real-life sub-analysis of the Italian DICE study 8
Follow-up evaluation and management of anemia in inflammatory bowel disease: A study by the Italian Group for Inflammatory Bowel Diseases (IG-IBD) 8
Ustekinumab is a promising option for the treatment of postoperative recurrence of Crohn's disease 7
Standard Therapeutic Approach and New Therapies 6
Safety and effectiveness of tofacitinib in ulcerative colitis: Data from TOFA-UC, a SN-IBD study 5
Psychological impairment in inflammatory bowel diseases: the key role of coping and defense mechanisms 4
The Effectiveness of Risankizumab as Induction Therapy for Crohn's Disease: Data From the Sicilian Network for Inflammatory Bowel Diseases 3
Suboptimal disease control and contributing factors in Italian IBD patients: The IBD-PODCAST Study 2
Totale 2.089
Salva come PNG Salva come JPEG
Categoria #
all - tutte 11.458
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.458
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202022 0 0 0 0 0 0 0 0 0 8 7 7
2020/2021152 15 12 32 4 15 4 18 5 5 19 16 7
2021/2022287 5 31 3 2 8 4 14 10 11 74 21 104
2022/2023597 39 65 26 53 29 45 14 28 268 11 13 6
2023/2024256 20 29 36 54 14 23 7 15 0 33 8 17
2024/2025730 16 21 16 79 60 76 94 194 174 0 0 0
Totale 2.089